Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Corcept Therapeutics Inc
CORT
Healthcare
Biotechnology
As of 04/21/1999, BCS Technologies, Inc. is a subsidiary of Cortelco Systems.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:CORT)
New Post
View:
Posts & Comments
Threaded Posts
(0)
•••
krbcan
X
Post by
krbcan
on Mar 16, 2017 11:43am
Patrick G. Enright Sells 600,000 Shares
https://www.chaffeybreeze.com/2017/03/15/patrick-g-enright-sells-600000-shares-of-corcept-therapeutics-incorporated-cort-stock.html Director Patrick G. Enright sold 600,000 shares of the firm’s stock
...more
(0)
•••
krbcan
X
Post by
krbcan
on Oct 11, 2016 1:27pm
Seeking Alpha - Oct 10, 2016
https://seekingalpha.com/article/4011328-corcept-therapeutics-cushings-syndrome-just-beginning Summary Shares are up over 40% since the beginning of the year, but there's plenty of
...more
(0)
•••
krbcan
X
Post by
krbcan
on Feb 19, 2016 1:31pm
Reference to Corcept as "Strong Buy" from Zacks
https://finance.yahoo.com/news/aerie-aeri-reports-positive-interim-210509990.html Some better-ranked stocks in the health care sector include Corcept Therapeutics Incorporated CORT, Auris Medical
...more
(0)
•••
krbcan
X
Post by
krbcan
on Dec 18, 2015 5:23pm
$8 target
Janney Montgomery Scott initiated coverage on shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) in a report published on Thursday, Market Beat reports. The brokerage issued a buy rating and a
...more
(0)
•••
krbcan
X
Post by
krbcan
on Jun 10, 2015 2:47pm
52 week high today
Day's Range: 6.15 - 6.80
(0)
•••
krbcan
X
Post by
krbcan
on Jun 08, 2015 4:35pm
$12 Target
April 22 - Corcept Therapeutics Inc. (NASDAQ:CORT) received a Buy rating and a $12 price target from FBR Capital analystChristopher James..... https://www.analystratings.com/2015/04/22/corcept
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Sego completes four drill holes at South Gold Zone, Cuba Zone deep hole underway